EFG Asset Management (North America) Corp. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
EFG Asset Management (North America) Corp. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,093,873
+11.3%
151,068
+7.9%
0.74%
+23.3%
Q2 2023$2,779,457
+17.5%
140,023
+1.4%
0.60%
+14.0%
Q1 2023$2,365,572
+7.8%
138,055
+22.7%
0.52%
+6.1%
Q4 2022$2,193,789112,5020.49%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders